Please enable JS

Phoenix Clinical Research

At Phoenix Clinical Research, they take great pride in their commitment to delivering exceptional services, ensuring precision, and strict adherence to protocols through their unparalleled clinical trial monitoring expertise. Their efficient project management approach guarantees seamless coordination and timely execution of all trial aspects, setting them apart as a reliable partner. With a strong focus on excellence, integrity, and innovation, Phoenix CR strives to contribute significantly to cutting-edge healthcare solutions. Leveraging their in-depth understanding of the region’s regulatory landscape, they provide expert solutions encompassing protocol design, site selection, patient recruitment, and regulatory submissions. Clients can rely on Phoenix CR to navigate the complexities of clinical research with utmost professionalism and dedication.”

 

Learn more: www.phoenix-cr.com

A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT

64 +

countries
involved

20 000 +

investigational
Centres

3 million +

patients
in database

50 000 +

users
worlwide

telemedicine technologies earth

LATEST NEWSOUR NEWS >

telemedecine technologies news

Telemedicine Technologies will be at Swiss Biotech Day 2025

April 29, 2025

May 5 & 6 – Basel Telemedicine Technologies is pleased to present its CleanWeb™ eClinical suite, offering flexible, regulatory-compliant solutions tailored to every phase of clinical trials. Our platform includes a wide range of modules, such as eCRF, Randomization & Trial Supply Management, ePRO, eTMF, eConsent, Data Visualization, Vigilance, Imaging, CTMS, and more. We invite […]

READ MORE
telemedecine technologies news

Drug development cost pharma $2.2B per asset in 2024 as GLP-1s drive financial return

April 29, 2025

Fierce Biotech The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. The data come from 20 pharmas that had the highest R&D budgets in 2020, as reported in Deloitte’s annual report, “Measuring the return from pharmaceutical innovation.” In 2024, the average […]

READ MORE
telemedecine technologies news

Adopting Flexible Strategies to Combat Capacity Shortages

April 29, 2025

Biopharm International In January 2025, Samsung Biologics signed a six-year, $1.4 billion contract manufacturing agreement with an as-yet undisclosed European pharmaceutical company, with production to take place at Samsung’s manufacturing site in Songdo, South Korea (1). Simultaneously, at the J.P. Morgan Healthcare Conference held in San Francisco, the company announced plans to complete construction of […]

READ MORE